HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takashi Nakamura Selected Research

Oxidized LDL Receptors

4/2012Lectin-like oxidized low-density lipoprotein receptor 1 signal is a potent biomarker and therapeutic target for human rheumatoid arthritis.
11/2004Lectin-like oxidized low-density lipoprotein receptor 1 mediates matrix metalloproteinase 3 synthesis enhanced by oxidized low-density lipoprotein in rheumatoid arthritis cartilage.
11/2002LOX-1 expressed in cultured rat chondrocytes mediates oxidized LDL-induced cell death-possible role of dephosphorylation of Akt.
9/2002Lectin-like oxidized low-density lipoprotein receptor 1 mediates leukocyte infiltration and articular cartilage destruction in rat zymosan-induced arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takashi Nakamura Research Topics

Disease

70Neoplasms (Cancer)
09/2022 - 01/2002
18Rheumatoid Arthritis
01/2017 - 08/2004
12Insulin Resistance
01/2022 - 04/2003
12Osteoarthritis
03/2016 - 11/2002
11Neoplasm Metastasis (Metastasis)
05/2022 - 08/2002
10Inflammation (Inflammations)
05/2021 - 08/2004
10Bone Resorption
08/2017 - 04/2002
9Heart Failure
01/2021 - 06/2012
8Osteoporosis
09/2022 - 01/2003
8Hypertrophy
05/2022 - 01/2006
8Obesity
09/2021 - 05/2018
8Body Weight (Weight, Body)
01/2021 - 02/2002
7Fibrosis (Cirrhosis)
05/2022 - 05/2007
7Pain (Aches)
03/2022 - 01/2002
7Liver Diseases (Liver Disease)
01/2022 - 11/2018
7Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2017
7Hyperuricemia
01/2022 - 02/2018
7Infections
07/2021 - 03/2003
7Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 02/2008
7Urinary Bladder Neoplasms (Bladder Cancer)
12/2018 - 06/2011
6Osteonecrosis (Kienbock's Disease)
03/2022 - 08/2003
6Stomach Neoplasms (Stomach Cancer)
07/2019 - 03/2002
6Arthritis (Polyarthritis)
04/2012 - 09/2002
5Breast Neoplasms (Breast Cancer)
04/2021 - 09/2002
5Atherosclerosis
01/2021 - 09/2002
5Melanoma (Melanoma, Malignant)
01/2021 - 03/2002
5Chronic Renal Insufficiency
01/2021 - 08/2007
5Carcinoma (Carcinomatosis)
01/2017 - 01/2003
5Knee Osteoarthritis
10/2015 - 04/2007
5Spinal Cord Diseases
02/2012 - 01/2002
5Synovial Sarcoma (Synovioma)
09/2008 - 10/2002
4Fatigue
05/2022 - 05/2004
4Diabetes Mellitus
08/2021 - 01/2017
4Ischemia
07/2021 - 03/2002
4Lymphatic Metastasis
04/2021 - 06/2002
4Bites and Stings (Sting)
01/2021 - 06/2014
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 08/2004
4Hypoxia (Hypoxemia)
01/2018 - 01/2010
4Colitis
02/2017 - 08/2015
4Osteosarcoma (Osteogenic Sarcoma)
04/2011 - 08/2002
3Acute Kidney Injury (Acute Renal Failure)
01/2022 - 11/2018
3Hypertension (High Blood Pressure)
09/2021 - 05/2014
3Hyperemia
05/2021 - 03/2002
3Thrombosis (Thrombus)
11/2020 - 01/2003

Drug/Important Bio-Agent (IBA)

27Xanthine DehydrogenaseIBA
04/2022 - 06/2016
17Proteins (Proteins, Gene)FDA Link
01/2019 - 06/2002
14LipidsIBA
05/2022 - 11/2002
11Uric Acid (Urate)IBA
01/2022 - 06/2016
11CytokinesIBA
01/2020 - 01/2002
10Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2010
9Pharmaceutical PreparationsIBA
01/2022 - 02/2002
9Glucose (Dextrose)FDA LinkGeneric
01/2021 - 01/2006
8Small Interfering RNA (siRNA)IBA
09/2022 - 07/2015
8Messenger RNA (mRNA)IBA
09/2022 - 03/2002
8AntigensIBA
01/2022 - 08/2009
7Liposomes (Liposome)IBA
01/2022 - 06/2011
7Lipid NanoparticlesIBA
01/2022 - 01/2016
7LigandsIBA
01/2022 - 04/2006
6XanthineIBA
01/2022 - 01/2019
6CollagenIBA
08/2021 - 07/2002
6EnzymesIBA
05/2021 - 02/2007
6Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 01/2018
5Biological ProductsIBA
01/2020 - 08/2002
5Transcription Factors (Transcription Factor)IBA
01/2020 - 12/2006
5Heparin (Liquaemin)FDA LinkGeneric
04/2016 - 04/2004
5Interleukin-6 (Interleukin 6)IBA
08/2015 - 01/2002
4Therapeutic UsesIBA
05/2022 - 04/2005
4Insulin (Novolin)FDA Link
12/2021 - 01/2016
4Alanine Transaminase (SGPT)IBA
12/2021 - 08/2004
4FYX-051IBA
01/2021 - 06/2016
4Immune Checkpoint InhibitorsIBA
01/2021 - 01/2018
4Triglycerides (Triacylglycerol)IBA
01/2020 - 04/2003
4AdiponectinIBA
01/2020 - 01/2017
4CreatinineIBA
01/2020 - 08/2007
4SteroidsIBA
12/2018 - 08/2003
4Cell Wall SkeletonIBA
01/2016 - 06/2011
4Oxidized LDL ReceptorsIBA
04/2012 - 09/2002
4LectinsIBA
04/2012 - 09/2002
4Hyaluronic Acid (Hyaluronan)IBA
03/2012 - 01/2007
3DNA (Deoxyribonucleic Acid)IBA
09/2022 - 11/2018
3Levodopa (L Dopa)FDA LinkGeneric
05/2022 - 09/2019
3HypoxanthineIBA
01/2022 - 07/2020
3Aspartate Aminotransferases (Aspartate Transaminase)IBA
12/2021 - 08/2004
3HDL CholesterolIBA
12/2021 - 01/2018
3Brain Natriuretic Peptide (Natrecor)FDA Link
09/2021 - 01/2020
3Oxygen (Dioxygen)IBA
07/2021 - 04/2004
3InterferonsIBA
01/2021 - 06/2014
3propagermanium (Ge 132)IBA
01/2021 - 02/2011

Therapy/Procedure

46Therapeutics
05/2022 - 03/2002
22Immunotherapy
01/2022 - 03/2011
7Osteotomy
01/2019 - 01/2007
6Transplantation
03/2022 - 08/2003
6Drug Therapy (Chemotherapy)
07/2019 - 07/2002
5Conservative Treatment
01/2021 - 01/2002
5Aftercare (After-Treatment)
11/2017 - 04/2003
5Radiotherapy
11/2012 - 01/2005
4Glycemic Control
08/2021 - 03/2016
4Laminoplasty
02/2012 - 09/2006
3Percutaneous Coronary Intervention
02/2022 - 01/2021
3Surgical Amputation (Amputations)
07/2021 - 06/2008